Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Sex Linked Disorders

Sex Linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.

Cushing Syndrome II: Pathophysiology

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...

Cushing Syndrome I: Introduction

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...

Sex-linked Disorders

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.

Lethal Alleles

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...

Huntington Disease l: Introduction

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Observance of antifibrotic treatment in the French OPALE support program for patients with pulmonary fibrosis].

Revue des maladies respiratoires·2026

Same author

Value of the chewing gum test for the diagnosis of giant cell arteritis: a multicentre pilot study.

Scandinavian journal of rheumatology·2026

Same author

Identifying giant cell arteritis patients with higher risk of relapse and vascular events: a cluster analysis.

QJM : monthly journal of the Association of Physicians·2024

Same author

Outcome and prognosis of isolated carotid vasculitis.

Journal of autoimmunity·2024

Same author

[Gastrointestinal tract involvement in systemic sclerosis].

La Revue de medecine interne·2023

Same author

Necrotizing myopathy associated with TET2-mutated myelodysplastic syndrome.

QJM : monthly journal of the Association of Physicians·2022

Same journal

[Atypical low back pain].

La Revue de medecine interne·2026

Same journal

[Polycythemia associated chronic haemolysis].

La Revue de medecine interne·2026

Same journal

[Persistent headaches in a 55 year-old man].

La Revue de medecine interne·2026

Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026

Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026

Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026

See all related articles

Search research articles

Related Experiment Videos

[Gleich's syndrome: a case report].

C Agard¹, S Evain, T Ponge

¹Service de médecine interne, CHU Hôtel-Dieu, place Alexis-Ricordeau, 44035 Nantes cedex 01, France. christian.agard@chu-nantes.fr <christian.agard@chu-nantes.fr>

La Revue De Medecine Interne

|January 3, 2009

Summary

This summary is machine-generated.

Gleich's syndrome, a rare condition causing recurrent angioedema and eosinophilia, typically responds well to corticosteroids. This case study highlights the favorable prognosis and suggests mepolizumab as an alternative treatment option.

Related Experiment Videos

Area of Science:

Internal Medicine
Dermatology
Allergy and Immunology

Background:

Gleich's syndrome is a rare disorder characterized by recurrent angioedema and significant eosinophilia.
It typically shows a positive response to corticosteroid therapy.

Observation:

A 53-year-old male patient with Gleich's syndrome was monitored over a 6-year period.
The case involved recurrent angioedema and marked eosinophilia.

Findings:

The patient's condition demonstrated a favorable prognosis over the 6-year follow-up.
Corticosteroids were effective in managing the symptoms of Gleich's syndrome.

Implications:

This case emphasizes the generally good outlook for individuals diagnosed with Gleich's syndrome.
Mepolizumab is proposed as a potential therapeutic option for patients intolerant to corticosteroids.